WHO INFORME 58 - ABRIL 2025 - TRS 1060





Link para descargar el documento

 https://iris.who.int/bitstream/handle/10665/381072/9789240108264-eng.pdf?sequence=1


WHO TRS 1060 INFORME 58

Annex 1
Guidelines and guidance texts adopted by the Expert Committee on Specifications for
Pharmaceutical Preparations 

Annex 2
WHO good practice considerations for the prevention and control of nitrosamines in
pharmaceutical products 

Annex 3 
WHO good manufacturing practices for excipients used in pharmaceutical products 

Annex 4 
Good practices for blood establishments 

Annex 5 
WHO Biowaiver List: proposal to waive in vivo bioequivalence requirements for WHO
Model List of Essential Medicines immediate-release, solid oral dosage forms 

Annex 6
Guideline on bioanalytical method validation and study sample analysis 

Annex 7
Good practices of national regulatory authorities in implementing the collaborative
registration procedures for medical products 

Annex 8
Collaborative registration procedure between WHO and national regulatory
authorities in the assessment and accelerated national registration of
WHO-prequalified vector control products 

Annex 9
Guidance for the graphic representation of chemical structures of pharmaceutical
substances in the publications of International Nonproprietary Names and
The International Pharmacopoeia 



WHO TRS 1060 INFORME 58